Latest Updates

Lupin’s Budesonide Inhalation Suspension, 0.5 mg/2 mL Single-Dose Ampules is a generic version of AstraZeneca Pharmaceuticals LP’s…

The trial has been testing the drug, Depatux-M, to treat an aggressive form of brain cancer known as glioblastoma

The state-of-the art facility in the domestic tariff area (DTA) is part of Thermo Fisher’s clinical trials business and was built…

WuXi STA will now provide Dizal integrated CMC (Chemical, manufacturing and Control) process research and manufacturing services…

Also, for the fiscal year ended March 2019, the company posted a net profit of Rs 436 crore as against Rs 678 crore for the…

The US FDA approved the Abbreviated New Drug Application for Solifenacin Succinate Tablets, which are a generic version of…

The company recently released its consolidated financial results, wherein it reported a 21 per cent hike in net revenue for FY19

The R&D spend for the quarter (January-March FY 19) is Rs 366 crore, that is USD 53 million and EBIT 9.19 per cent of the…

The AstraZeneca alleged that the Indian drug makers proposed generic Daliresp would infringe the patents on three counts and…

The company reported a 28.5 per cent growth in revenues at Rs 20,390 mn and a growth of 11.6 per cent in net profits for FY19;…